The Role of Inferior Alveolar Nerve Involvement in Bisphosphonate-Related Osteonecrosis of the Jaw

Journal of Oral and Maxillofacial Surgery

Volumn 67, Issue 3, 2009, Pages 589-592

  Otto, Sven ^a   Hafner, Sigurd ^a   Grötz, Knut A ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b Horst Schmidt Klinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; IBANDRONIC ACID; METHOTREXATE; SULTAMICILLIN; ZOLEDRONIC ACID;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; INFERIOR ALVEOLAR NERVE; JAW OSTEONECROSIS; MALE; MULTIPLE CYCLE TREATMENT; POSTOPERATIVE CARE; PREOPERATIVE CARE; TREATMENT DURATION;

AGED; ANTI-BACTERIAL AGENTS; BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FEMALE; GINGIVITIS, NECROTIZING ULCERATIVE; HUMANS; IMIDAZOLES; MALE; MANDIBULAR DISEASES; MANDIBULAR NERVE; MIDDLE AGED; OSTEONECROSIS; SOMATOSENSORY DISORDERS;

EID: 60249087667     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joms.2008.09.028     Document Type: Article

References (16)

1. Marx R.E. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg 61 (2003) 1115
2. Yarom N., Yahalom R., Shoshani Y., et al. Osteonecrosis of the jaw induced by orally administered bisphosphonates: Incidence, clinical features, predisposing factors and treatment outcome. Osteoporos Int 18 (2007) 1363
3. Wang E.P., Kaban L.B., Strewler G.J., et al. Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy. J Oral Maxillofac Surg 65 (2007) 1328
4. Bamias A., Kastritis E., Bamia C., et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors. J Clin Oncol 23 (2005) 8580
5. Khosla S., Burr D., Cauley J., et al. Bisphosphonate-associated osteonecrosis of the jaw: Report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22 (2007) 1479
6. Reid I.R., Bolland M.J., and Grey A.B. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?. Bone 41 (2007) 318
7. Diel I.J., Fogelman I., Al Nawas B., et al. Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?. Crit Rev Oncol Hematol 64 (2007) 198
8. Vincent B. Sur un signe precoce de certaines osteites du maxillaire inferrieur de terminant par necrose. Rev Trimestr Suisse d'Odontol 6 (1896) 148
9. Thomson P.J., and Rood J.P. Mental nerve dysfunction: A symptom of diverse mandibular disease. Dent Update 22 (1995) 271
10. Baltensperger M., Gratz K., Bruder E., et al. Is primary chronic osteomyelitis a uniform disease?. Proposal of a classification based on a retrospective analysis of patients treated in the past 30 years. J Craniomaxillofac Surg 32 (2004) 43
11. Barrett A.P., and Buckley D.J. Selective anesthesias of peripheral branches of the trigeminal nerve due to odontogenic infection. Oral Surg Oral Med Oral Pathol 62 (1986) 226
12. Grotz K.A., Al Nawas B., de Aguiar E.G., et al. Treatment of injuries to the inferior alveolar nerve after endodontic procedures. Clin Oral Investig 2 (1998) 73
13. Morse D.R. Infection-related mental and inferior alveolar nerve paresthesia: Literature review and presentation of two cases. J Endod 23 (1997) 457
14. Reboiras L., Garcia G.A., Antunez L.J., et al. Anaesthesia of the right lower hemilip as a first manifestation of multiple myeloma. Presentation of a clinical case. Med Oral 6 (2001) 168
15. Zanglis A., Andreopoulos D., Dima M., et al. Jaw uptake of technetium-99 methylene diphosphonate in patients on biphosphonates: A word of caution. Hell J Nucl Med 10 (2007) 177
16. Weitzman R., Sauter N., Eriksen E.F., et al. Critical review: Updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients-May 2006. Crit Rev Oncol Hematol 62 (2007) 148